Vasoreactivity in Carriers of Genetic Polymorphisms
Status:
Unknown status
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to assess the impact of genetic variation (especially
polymorphisms of the gene coding endothelial nitric oxide synthase (eNOS) and the bradykinin
B2 receptor gene) on venous and arterial responsiveness to vasodilators in healthy
individuals without cardiovascular risk factors.